Cargando…
Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants
Allogeneic islet transplantation is a promising cell-based therapy for Type 1 Diabetes (T1D). The long-term efficacy of this approach, however, is impaired by allorejection. Current clinical practice relies on long-term systemic immunosuppression, leading to severe adverse events. To avoid these det...
Autores principales: | Li, Ying, Frei, Anthony W., Labrada, Irayme M., Rong, Yanan, Liang, Jia-Pu, Samojlik, Magdalena M., Sun, Chuqiao, Barash, Steven, Keselowsky, Benjamin G., Bayer, Allison L., Stabler, Cherie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190479/ https://www.ncbi.nlm.nih.gov/pubmed/34122410 http://dx.doi.org/10.3389/fimmu.2021.653088 |
Ejemplares similares
-
Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance
por: Headen, Devon M., et al.
Publicado: (2018) -
PEGDA microencapsulated allogeneic islets reverse canine diabetes without immunosuppression
por: Harrington, Stephen, et al.
Publicado: (2022) -
The Foundation for Engineering a Pancreatic Islet Niche
por: Patel, Smit N., et al.
Publicado: (2022) -
Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2017) -
Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability
por: Burke, Jacqueline A., et al.
Publicado: (2022)